Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Samuel Gold is a urologic oncologist and researcher whose work sits at the intersection of advanced imaging, surgical innovation, and improved cancer staging. His primary research focuses on refining the use of multiparametric MRI (mpMRI) to better characterize prostate cancer, particularly through his landmark 2019 study that developed a novel grading system for assessing the risk of extraprostatic extension (EPE). This highly influential work, which has garnered 238 citations, provides radiologists and surgeons with a standardized, evidence-based framework to predict tumor spread before surgery—a critical factor in treatment planning. Dr. Gold has also pioneered the integration of cutting-edge technology into the operating room, demonstrating the feasibility of a virtual reality (VR) surgical navigation tool for robotic-assisted radical prostatectomy. Beyond prostate cancer, his research portfolio extends to renal cell carcinoma with challenging inferior vena cava tumor thrombus, where he has assessed progress in surgical outcomes and complications. With additional contributions to perioperative chemotherapy for upper tract urothelial carcinoma and the evaluation of novel fluorophores like rizedisben for nerve identification during minimally invasive surgery, Dr. Gold is a forward-thinking clinician-scientist dedicated to making urologic surgery safer, more precise, and more personalized.